The DOI matches its Crossref record; 202 of the 202 references it cites were found in a registry or an index.
Insights into new mechanisms and models of cancer stem cell multidrug resistance
Abstract
The acquisition of genetic alterations, clonal evolution, and the tumor microenvironment promote cancer progression, metastasis and therapy resistance. These events correspond to the establishment of the great phenotypic heterogeneity and plasticity of cancer cells that contribute to tumor progression and resistant disease. Targeting resistant cancers is a major challenge in oncology; however, the underlying processes are not yet fully understood. Even though current treatments can reduce tumor size and increase life expectancy, relapse and multidrug resistance (MDR) ultimately remain the second cause of death in developed countries. Recent evidence points toward stem-like phenotypes in cancer cells, promoted by cancer stem cells (CSCs), as the main culprit of cancer relapse, resistance (radiotherapy, hormone therapy, and/or chemotherapy) and metastasis. Many mechanisms have been proposed for CSC resistance, such as drug efflux through ABC transporters, overactivation of the DNA damage response (DDR), apoptosis evasion, prosurvival pathways activation, cell cycle promotion and/or cell metabolic alterations. Nonetheless, targeted therapy toward these specific CSC mechanisms is only partially effective to prevent or abolish resistance, suggesting underlying additional causes for CSC resilience. This article aims to provide an integrated picture of the MDR mechanisms that operate in CSCs' behavior and to propose a novel model of tumor evolution during chemotherapy. Targeting the pathways mentioned here might hold promise and reveal new strategies for future clinical therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Chen, C.-L., Uthaya Kumar, D. B., Punj, V., Xu, J., Sher, L., Tahara, S. M., Hess, S., & Machida, K. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.004 · Cited by 388
RetractedDas, S., Mukherjee, P., Chatterjee, R., Jamal, Z., & Chatterji, U. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0409 · Cited by 81
RetractedBray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
The Warburg Effect: How Does it Benefit Cancer Cells?
Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.12.001 · Cited by 5,150
The metabolism of tumors in the body
Warburg, O., Wind, F., & Negelein, E. (1927) · Journal of General Physiology · doi:10.1085/jgp.8.6.519 · Cited by 4,416
The multilayered complexity of ceRNA crosstalk and competition
Tay, Y., Rinn, J., & Pandolfi, P. P. (2014) · Nature · doi:10.1038/nature12986 · Cited by 3,910
Ceramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes
Trajkovic, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., Schwille, P., Brügger, B., & Simons, M. (2008) · Science · doi:10.1126/science.1153124 · Cited by 3,627
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.027 · Cited by 2,770
Levy, J. M. M., Towers, C. G., & Thorburn, A. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.53 · Cited by 2,526
Tumour heterogeneity and cancer cell plasticity
Meacham, C. E., & Morrison, S. J. (2013) · Nature · doi:10.1038/nature12624 · Cited by 2,446
A restricted cell population propagates glioblastoma growth after chemotherapy
Chen, J., Li, Y., Yu, T.-S., McKay, R. M., Burns, D. K., Kernie, S. G., & Parada, L. F. (2012) · Nature · doi:10.1038/nature11287 · Cited by 2,354
Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A.-M., Sampath, J., Morris, J. J., Lagutina, I., Grosveld, G. C., Osawa, M., Nakauchi, H., et al. (2001) · Nature Medicine · doi:10.1038/nm0901-1028 · Cited by 2,280
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
Ding, L., Ley, T. J., Larson, D. E., Miller, C. A., Koboldt, D. C., Welch, J. S., Ritchey, J. K., Young, M. A., Lamprecht, T., McLellan, M. D., et al. (2012) · Nature · doi:10.1038/nature10738 · Cited by 1,993
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
Vermeulen, L., De Sousa E Melo, F., van der Heijden, M., Cameron, K., de Jong, J. H., Borovski, T., Tuynman, J. B., Todaro, M., Merz, C., Rodermond, H., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2048 · Cited by 1,804
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma
Liu, G., Yuan, X., Zeng, Z., Tunici, P., Ng, H., Abdulkadir, I. R., Lu, L., Irvin, D., Black, K. L., & Yu, J. S. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-67 · Cited by 1,790
The landscape of genomic alterations across childhood cancers
ICGC PedBrain-Seq Project, Gröbner, S. N., ICGC MMML-Seq Project, Worst, B. C., Weischenfeldt, J., Buchhalter, I., Kleinheinz, K., Rudneva, V. A., Johann, P. D., Balasubramanian, G. P., et al. (2018) · Nature · doi:10.1038/nature25480 · Cited by 1,572
Targeting metastasis-initiating cells through the fatty acid receptor CD36
Pascual, G., Avgustinova, A., Mejetta, S., Martín, M., Castellanos, A., Attolini, C. S.-O., Berenguer, A., Prats, N., Toll, A., Hueto, J. A., et al. (2017) · Nature · doi:10.1038/nature20791 · Cited by 1,437
The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells
Cordenonsi, M., Zanconato, F., Azzolin, L., Forcato, M., Rosato, A., Frasson, C., Inui, M., Montagner, M., Parenti, A. R., Poletti, A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.048 · Cited by 1,381
Anoikis molecular pathways and its role in cancer progression
Paoli, P., Giannoni, E., & Chiarugi, P. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.026 · Cited by 1,160
The perivascular niche regulates breast tumour dormancy
Ghajar, C. M., Peinado, H., Mori, H., Matei, I. R., Evason, K. J., Brazier, H., Almeida, D., Koller, A., Hajjar, K. A., Stainier, D. Y. R., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2767 · Cited by 1,148
The impact of the endoplasmic reticulum protein-folding environment on cancer development
Wang, M., & Kaufman, R. J. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3800 · Cited by 1,112
Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance
Easwaran, H., Tsai, H.-C., & Baylin, S. B. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.05.015 · Cited by 915
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
Lawson, D. A., Bhakta, N. R., Kessenbrock, K., Prummel, K. D., Yu, Y., Takai, K., Zhou, A., Eyob, H., Balakrishnan, S., Wang, C.-Y., et al. (2015) · Nature · doi:10.1038/nature15260 · Cited by 893
Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways
Boelens, M. C., Wu, T. J., Nabet, B. Y., Xu, B., Qiu, Y., Yoon, T., Azzam, D. J., Twyman-Saint Victor, C., Wiemann, B. Z., Ishwaran, H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.051 · Cited by 806
Cancer stem cells: The challenges ahead
Medema, J. P. (2013) · Nature Cell Biology · doi:10.1038/ncb2717 · Cited by 741
Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration
Jopling, C., Boue, S., & Belmonte, J. C. I. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3043 · Cited by 730
Translational Regulation of Gene Expression during Conditions of Cell Stress
Spriggs, K. A., Bushell, M., & Willis, A. E. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.028 · Cited by 723
MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells
Sancho, P., Burgos-Ramos, E., Tavera, A., Bou Kheir, T., Jagust, P., Schoenhals, M., Barneda, D., Sellers, K., Campos-Olivas, R., Graña, O., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.08.015 · Cited by 722
Lee, K.-M., Giltnane, J. M., Balko, J. M., Schwarz, L. J., Guerrero-Zotano, A. L., Hutchinson, K. E., Nixon, M. J., Estrada, M. V., Sánchez, V., Sanders, M. E., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.09.009 · Cited by 650
ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Choi, Y., & Yu, A.-M. (2014) · Current Pharmaceutical Design · doi:10.2174/138161282005140214165212 · Cited by 629
Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
Schwickart, M., Huang, X., Lill, J. R., Liu, J., Ferrando, R., French, D. M., Maecker, H., O’Rourke, K., Bazan, F., Eastham-Anderson, J., et al. (2010) · Nature · doi:10.1038/nature08646 · Cited by 628
Hallmarks of cancer stem cell metabolism
Sancho, P., Barneda, D., & Heeschen, C. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.152 · Cited by 574
Safaei, R., Larson, B. J., Cheng, T. C., Gibson, M. A., Otani, S., Naerdemann, W., & Howell, S. B. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0102 · Cited by 564
Kuntz, E. M., Baquero, P., Michie, A. M., Dunn, K., Tardito, S., Holyoake, T. L., Helgason, G. V., & Gottlieb, E. (2017) · Nature Medicine · doi:10.1038/nm.4399 · Cited by 546
Dedifferentiation and reprogramming: origins of cancer stem cells
Friedmann‐Morvinski, D., & Verma, I. M. (2014) · EMBO reports · doi:10.1002/embr.201338254 · Cited by 495
Therapy-induced tumour secretomes promote resistance and tumour progression
Obenauf, A. C., Zou, Y., Ji, A. L., Vanharanta, S., Shu, W., Shi, H., Kong, X., Bosenberg, M. C., Wiesner, T., Rosen, N., et al. (2015) · Nature · doi:10.1038/nature14336 · Cited by 494
Peiris-Pagès, M., Martinez-Outschoorn, U. E., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0712-6 · Cited by 465
PI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical application.
Pu, X., & Xu, X. (2015) · Europe PMC (PubMed Central) · Cited by 453
Rangwala, R., Chang, Y. C., Hu, J., Algazy, K. M., Evans, T. L., Fecher, L. A., Schuchter, L. M., Torigian, D. A., Panosian, J. T., Troxel, A. B., et al. (2014) · Autophagy · doi:10.4161/auto.29119 · Cited by 424
Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy
Lan, X., Jörg, D. J., Cavalli, F. M. G., Richards, L. M., Nguyen, L. V., Vanner, R. J., Guilhamon, P., Lee, L., Kushida, M. M., Pellacani, D., et al. (2017) · Nature · doi:10.1038/nature23666 · Cited by 405
Phuphanich, S., Wheeler, C. J., Rudnick, J. D., Mazer, M., Wang, H., Nuño, M. A., Richardson, J. E., Fan, X., Ji, J., Chu, R. M., et al. (2013) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-012-1319-0 · Cited by 388
TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells
Bartucci, M., Dattilo, R., Moriconi, C., Pagliuca, A., Mottolese, M., Federici, G., Benedetto, A. D., Todaro, M., Stassi, G., Sperati, F., et al. (2015) · Oncogene · doi:10.1038/onc.2014.5 · Cited by 350
CD44v6 Dependence of Premetastatic Niche Preparation by Exosomes
Jung, T., Castellana, D., Klingbeil, P., Hernández, I. C., Vitacolonna, M., Orlicky, D. J., Roffler, S. R., Brodt, P., & Zöller, M. (2009) · Neoplasia · doi:10.1593/neo.09822 · Cited by 345
Cancer stem cells, cancer cell plasticity and radiation therapy
Vlashi, E., & Pajonk, F. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.07.001 · Cited by 327
Chk2 Phosphorylation of BRCA1 Regulates DNA Double-Strand Break Repair
Zhang, J., Willers, H., Feng, Z., Ghosh, J. C., Kim, S., Weaver, D. T., Chung, J. H., Powell, S. N., & Xia, F. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.708-718.2004 · Cited by 323
Minimal functional driver gene heterogeneity among untreated metastases
Reiter, J. G., Makohon-Moore, A. P., Gerold, J. M., Heyde, A., Attiyeh, M. A., Kohutek, Z. A., Tokheim, C. J., Brown, A., DeBlasio, R. M., Niyazov, J., et al. (2018) · Science · doi:10.1126/science.aat7171 · Cited by 307
Mechanisms that link the oncogenic epithelial–mesenchymal transition to suppression of anoikis
Frisch, S. M., Schaller, M., & Cieply, B. (2013) · Journal of Cell Science · doi:10.1242/jcs.120907 · Cited by 295
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer
Dey, P., Baddour, J., Muller, F., Wu, C. C., Wang, H., Liao, W.-T., Lan, Z., Chen, A., Gutschner, T., Kang, Y., et al. (2017) · Nature · doi:10.1038/nature21052 · Cited by 264
Wang, X., Schoenhals, J. E., Li, A., Valdecanas, D. R., Ye, H., Zang, F., Tang, C., Tang, M., Liu, C.-G., Liu, X., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-15-3142 · Cited by 261
De Luca, A., Fiorillo, M., Peiris-Pagès, M., Ozsvari, B., Smith, D. L., Sanchez-Alvarez, R., Martinez-Outschoorn, U. E., Cappello, A. R., Pezzi, V., Lisanti, M. P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4401 · Cited by 259
Facchino, S., Abdouh, M., Chatoo, W., & Bernier, G. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1634-10.2010 · Cited by 253
Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells
Basu-Roy, U., Bayin, N. S., Rattanakorn, K., Han, E., Placantonakis, D. G., Mansukhani, A., & Basilico, C. (2015) · Nature Communications · doi:10.1038/ncomms7411 · Cited by 247
Mitophagy Controls the Activities of Tumor Suppressor p53 to Regulate Hepatic Cancer Stem Cells
Liu, K., Lee, J., Kim, J. Y., Wang, L., Tian, Y., Chan, S. T., Cho, C., Machida, K., Chen, D., & Ou, J.-H. J. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.09.022 · Cited by 245
Falletta, P., Sanchez-del-Campo, L., Chauhan, J., Effern, M., Kenyon, A., Kershaw, C. J., Siddaway, R., Lisle, R., Freter, R., Daniels, M. J., et al. (2017) · Genes & Development · doi:10.1101/gad.290940.116 · Cited by 239
IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling
Sheng, X., Nenseth, H. Z., Qu, S., Kuzu, O. F., Frahnow, T., Simon, L., Greene, S., Zeng, Q., Fazli, L., Rennie, P. S., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08152-3 · Cited by 228
Zhu, Y., Yu, F., Jiao, Y., Feng, J., Tang, W., Yao, H., Gong, C., Chen, J., Su, F., Zhang, Y., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0071 · Cited by 221
Dasatinib as a Single Agent in Triple-Negative Breast Cancer: Results of an Open-Label Phase 2 Study
Finn, R. S., Bengala, C., Ibrahim, N., Roché, H., Sparano, J., Strauss, L. C., Fairchild, J., Sy, O., & Goldstein, L. J. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0288 · Cited by 220
Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer
Raoof, S., Mulford, I. J., Frisco-Cabanos, H., Nangia, V., Timonina, D., Labrot, E., Hafeez, N., Bilton, S. J., Drier, Y., Ji, F., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0887-2 · Cited by 216
Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma
Shen, Y.-A., Wang, C.-Y., Hsieh, Y.-T., Chen, Y.-J., & Wei, Y.-H. (2015) · Cell Cycle · doi:10.4161/15384101.2014.974419 · Cited by 207
Farnie, G., Sotgia, F., & Lisanti, M. P. (2015) · Oncotarget · doi:10.18632/oncotarget.5401 · Cited by 205
Nanog signaling in cancer promotes stem-like phenotype and immune evasion
Noh, K. H., Kim, B. W., Song, K.-H., Cho, H., Lee, Y.-H., Kim, J. H., Chung, J.-Y., Kim, J.-H., Hewitt, S. M., Seong, S.-Y., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64057 · Cited by 194
Kumar, D., Gupta, D., Shankar, S., & Srivastava, R. K. (2015) · Oncotarget · doi:10.18632/oncotarget.2462 · Cited by 185
Cellular FLICE-Like Inhibitory Protein (C-FLIP): A Novel Target for Cancer Therapy
Safa, A., Day, T., & Wu, C.-H. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908783497087 · Cited by 184
Castagnoli, L., Cancila, V., Cordoba-Romero, S. L., Faraci, S., Talarico, G., Belmonte, B., Iorio, M. V., Milani, M., Volpari, T., Chiodoni, C., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0700-2 · Cited by 184
Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy
Bartucci, M., Svensson, S., Romania, P., Dattilo, R., Patrizii, M., Signore, M., Navarra, S., Lotti, F., Biffoni, M., Pilozzi, E., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.170 · Cited by 181
Li, L., Cao, B., Liang, X., Lu, S., Luo, H., Wang, Z., Wang, S., Jiang, J., Lang, J., & Zhu, G. (2019) · Oncogene · doi:10.1038/s41388-018-0627-z · Cited by 179
Li, X., Zhou, N., Wang, J., Liu, Z., Wang, X., Zhang, Q., Liu, Q., Gao, L., & Wang, R. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.01.014 · Cited by 177
Carruthers, R. D., Ahmed, S. U., Ramachandran, S., Strathdee, K., Kurian, K. M., Hedley, A., Gomez-Roman, N., Kalna, G., Neilson, M., Gilmour, L., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0569 · Cited by 176
Venere, M., Hamerlik, P., Wu, Q., Rasmussen, R. D., Song, L. A., Vasanji, A., Tenley, N., Flavahan, W. A., Hjelmeland, A. B., Bartek, J., et al. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.136 · Cited by 172
Boulding, T., McCuaig, R., Tan, A., Hardy, K., Wu, F., Dunn, J., Kalimutho, M., Sutton, C. R., Forwood, J. K., Bert, A. G., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-17913-x · Cited by 169
Pathania, R., Ramachandran, S., Mariappan, G., Thakur, P., Shi, H., Choi, J.-H., Manicassamy, S., Kolhe, R., Prasad, P. D., Sharma, S., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2249 · Cited by 165
Li, Z., Niu, H., Qin, Q., Yang, S., Wang, Q., Yu, C., Wei, Z., Jin, Z., Wang, X., Yang, A., et al. (2019) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2019.05.007 · Cited by 163
RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer
Liu, Y., Burness, M. L., Martin-Trevino, R., Guy, J., Bai, S., Harouaka, R., Brooks, M. D., Shang, L., Fox, A., Luther, T. K., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1348 · Cited by 162
Epigenetic Targeting of Ovarian Cancer Stem Cells
Wang, Y., Cardenas, H., Fang, F., Condello, S., Taverna, P., Segar, M., Liu, Y., Nephew, K. P., & Matei, D. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1022 · Cited by 161
ABCB5 Maintains Melanoma-Initiating Cells through a Proinflammatory Cytokine Signaling Circuit
Wilson, B. J., Saab, K. R., Ma, J., Schatton, T., Pütz, P., Zhan, Q., Murphy, G. F., Gasser, M., Waaga-Gasser, A. M., Frank, N. Y., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0582 · Cited by 151
Ma, F., Li, H., Wang, H., Shi, X., Fan, Y., Ding, X., Chen, L., Zhan, Q., Qian, H., & Xu, B. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.06.022 · Cited by 150
Autophagic homeostasis is required for the pluripotency of cancer stem cells
Sharif, T., Martell, E., Dai, C., Kennedy, B. E., Murphy, P., Clements, D. R., Kim, Y., Lee, P. W. K., & Gujar, S. A. (2016) · Autophagy · doi:10.1080/15548627.2016.1260808 · Cited by 149
Pagotto, A., Pilotto, G., Mazzoldi, E. L., Nicoletto, M. O., Frezzini, S., Pastò, A., & Amadori, A. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.327 · Cited by 145
Abubaker, K., Luwor, R. B., Zhu, H., McNally, O., Quinn, M. A., Burns, C. J., Thompson, E. W., Findlay, J. K., & Ahmed, N. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-317 · Cited by 142
Brusatol, an NRF2 inhibitor for future cancer therapeutic
Cai, S. J., Liu, Y., Han, S., & Yang, C. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0309-8 · Cited by 142
Giudice, F. S., Júnior, D. D. S. P., Nor, J. E., SQUARIZE, C. H., & CASTILHO, R. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058672 · Cited by 140
Wang, L., Liu, X., Ren, Y., Zhang, J., Chen, J., Zhou, W., Guo, W., Wang, X., Chen, H., Li, M., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2016.409 · Cited by 139
Redox Modulating NRF2: A Potential Mediator of Cancer Stem Cell Resistance
Ryoo, I.-G., Lee, S.-H., & Kwak, M.-K. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2428153 · Cited by 138
Huang, M., Chen, C. Y., Geng, J., Han, D. H., Wang, T., Xie, T., Wang, L., Wang, Y., Wang, C., Lei, Z., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.038 · Cited by 136
Finally, An Apoptosis-Targeting Therapeutic for Cancer
Croce, C. M., & Reed, J. C. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1248 · Cited by 133
Thyroid cancer stem-like cell exosomes: regulation of EMT via transfer of lncRNAs
Hardin, H. A., Helein, H., Meyer, K. K., Robertson, S., Zhang, R., Zhong, W., & Lloyd, R. V. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0065-0 · Cited by 133
Min, W., Bruhn, C., Grigaravičius, P., Zhou, Z., Li, F., Krüger, A., Siddeek, B., Greulich, K., Popp, O., Meisezahl, C., et al. (2013) · Nature Communications · doi:10.1038/ncomms3993 · Cited by 129
Kim, D., Choi, B.-H., Ryoo, I.-G., & Kwak, M. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0903-4 · Cited by 129
Chemotherapy induces stemness in osteosarcoma cells through activation of Wnt/β-catenin signaling
Martins‐Neves, S. R., Paiva‐Oliveira, D. I., Wijers‐Koster, P. M., Abrunhosa, A., Ribeiro, C., Bovée, J. V. M. G., Cleton-Jansen, A., & Gomes, C. M. F. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.013 · Cited by 126
Fiorillo, M., Lamb, R., Tanowitz, H. B., Cappello, A. R., Martinez‐Outschoorn, U., Sotgia, F., & Lisanti, M. P. (2016) · Aging · doi:10.18632/aging.100983 · Cited by 125
Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironment
Eguchi, T., Sogawa, C. A., Okusha, Y., Uchibe, K., Iinuma, R., Ono, K., Nakano, K., Murakami, J., Itoh, M., Arai, K., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191109 · Cited by 125
Nakano, M., Kikushige, Y., Miyawaki, K., Kunisaki, Y., Mizuno, S., Takenaka, K., Tamura, S., Okumura, Y., Ito, M., Ariyama, H., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0480-0 · Cited by 125
Peiris‐Pagès, M., Bonuccelli, G., Sotgia, F., & Lisanti, M. P. (2018) · Oncotarget · doi:10.18632/oncotarget.24285 · Cited by 124
The FOXM1–ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells
Hou, Y., Zhu, Q., Li, Z., Peng, Y., Yu, X., Yuan, B., Liu, Y., Liu, Y., Yin, L., Peng, Y., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.53 · Cited by 121
Crucial Role of Interleukin-4 in the Survival of Colon Cancer Stem Cells
Francipane, M. G., Alea, M. P., Lombardo, Y., Todaro, M., Medema, J. P., & Stassi, G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6874 · Cited by 120
Wang, N., Wang, Z., Peng, C. Y., You, J., Shen, J., Han, S., & Chen, J. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu187 · Cited by 116
Sun, R., Shen, S., Zhang, Y., Xu, C., Cao, Z., Wen, L., & Wang, J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.038 · Cited by 116
Circulating Glioma Cells Exhibit Stem Cell-like Properties
Liu, T., Xu, H., Huang, M., Ma, W., Saxena, D., Lustig, R. A., Alonso‐Basanta, M., Zhang, Z., O’Rourke, D. M., Zhang, L., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0650 · Cited by 116
Shimizu, M., & Tanaka, N. (2018) · Oncogene · doi:10.1038/s41388-018-0533-4 · Cited by 115
Akbarzadeh, M., Movassaghpour, A. A., Ghanbari, H. A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16940-y · Cited by 113
Walker, N. D., Elias, M. G., Guiro, K., Bhatia, R., Greco, S. J., Bryan, M., Gergues, M., Sandiford, O. A., Ponzio, N. M., Leibovich, S. J., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1304-z · Cited by 113
Crosstalk between DNA repair and cancer stem cell (CSC) associated intracellular pathways
Skvortsov, S., Debbage, P. L., Lukas, P. H., & Skvortsova, I. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.06.002 · Cited by 111
CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors
Saygin, C., Wiechert, A. C., Rao, V. S., Alluri, R. K., Connor, E. V., Thiagarajan, P. S., Hale, J. S., Li, Y., Chumakova, A. P., Jarrar, A., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20170438 · Cited by 110
The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy
Andreucci, E., Ruzzolini, J., Peppicelli, S., Bianchini, F., Laurenzana, A., Carta, F., Supuran, C. T., & Calorini, L. (2018) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1532419 · Cited by 109
Gallmeier, E., Hermann, P. C., Mueller, M.-T., Machado, J. G., Ziesch, A., Toni, E. N. D., Palagyi, A., Eisen, C., Ellwart, J. W., Rivera, J., et al. (2011) · Stem Cells · doi:10.1002/stem.595 · Cited by 106
ABCF2 , an Nrf2 target gene, contributes to cisplatin resistance in ovarian cancer cells
Bao, L., Wu, J., Dodson, M. B., de la Vega, E. M. R., Ning, Y., Zhang, Z., Yao, M., Zhang, D. D., Xu, C., & Yi, X. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22615 · Cited by 106
Thakur, B. L., & Ray, P. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0636-8 · Cited by 105
Effects of metformin on colorectal cancer stem cells depend on alterations in glutamine metabolism
Kim, J. H., Lee, K. J., Seo, Y., Kwon, J.-H., Yoon, J. P., Kang, J. Y., Lee, H. J., Park, S. J., Hong, S. P., Cheon, J. H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-18762-4 · Cited by 105
Alonso‐Alconada, L., Muinelo‐Romay, L., Madissoo, K., Díaz‐López, A., Krakstad, C., Trovik, J., Wik, E., Hapangama, D. K., Coenegrachts, L., Cano, A., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-223 · Cited by 103
Bhola, N. E., Jansen, V. M., Koch, J. P., Li, H., Formisano, L., Williams, J. A., Grandis, J. R., & Arteaga, C. L. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1640-t · Cited by 103
Piggott, L., Omidvar, N., Pérez, S. M., Eberl, M., & Clarkson, R. W. E. (2011) · Breast Cancer Research · doi:10.1186/bcr2945 · Cited by 100
Statins: a role in breast cancer therapy?
Borgquist, S., Bjarnadottir, O., Kimbung, S., & Ahern, T. P. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12806 · Cited by 100
miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer
Feliciano, A., Garcia‐Mayea, Y., Jubierre, L., Mir, C., Hummel, M., Castellví, J., Hernández‐Losa, J., Paciucci, R., Sansano, I., Sun, Y., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.544 · Cited by 99
Self-citationHu, Y., Guo, R., Wei, J., Zhou, Y., Ji, W., Liu, J., Zhi, X., & Zhang, J. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.363 · Cited by 98
Manic, G., Signore, M., Sistigu, A., Russo, G., Corradi, F., Siteni, S., Musella, M., Vitale, S., De Angelis, M. L., Pallocca, M., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-312623 · Cited by 98
Extracellular vesicles as new players in angiogenesis
Kholia, S., Ranghino, A., Garnieri, P., Lopatina, T., Deregibus, M. C., Rispoli, P., Brizzi, M. F., & Camussi, G. (2016) · Vascular Pharmacology · doi:10.1016/j.vph.2016.03.005 · Cited by 97
Sotgia, F., Fiorillo, M., & Lisanti, M. P. (2017) · Oncotarget · doi:10.18632/oncotarget.19612 · Cited by 97
Exosomes Regulate the Transformation of Cancer Cells in Cancer Stem Cell Homeostasis
Xu, J., Liao, K., & Zhou, W. (2018) · Stem Cells International · doi:10.1155/2018/4837370 · Cited by 97
Sicari, D., Fantuz, M., Bellazzo, A., Valentino, E., Apollonio, M., Pontisso, I., Cristino, F. D., Ferro, M. D., Bicciato, S., Sal, G. D., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0878-3 · Cited by 97
Mizuno, T., Suzuki, N., Makino, H., Furui, T., Morii, E., Aoki, H., Kunisada, T., Yano, M., Kuji, S., Hirashima, Y., et al. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.12.005 · Cited by 96
Chaudhary, A., Mondal, G., Kumar, V., Kattel, K., & Mahato, R. I. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.05.007 · Cited by 95
An, H., Kim, J. Y., Oh, E., Lee, N., Cho, Y., & Seo, J. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141919 · Cited by 94
GAO, Z.-Y., Liu, Z., Bi, M., Zhang, J., Han, Z., Han, X., WANG, H.-Y., Sun, G., & Liu, H. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3143 · Cited by 93
Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP/TAZ
Escoll, M., Gargini, R., Cuadrado, A., Antón, I. M., & Wandosell, F. G. (2017) · Oncogene · doi:10.1038/onc.2016.518 · Cited by 92
Song, K., Choi, C. H., Lee, H., Oh, S. J., Woo, S. R., Hong, S.-O., Noh, K. H., Cho, H., Chung, E. J., Kim, J., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0072 · Cited by 92
Economopoulou, P., Kaklamani, V., & Siziopikou, K. P. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0163 · Cited by 87
Gao, Y., Zhang, Z., Li, K., Gong, L., Yang, Q., Huang, X., Hong, C., Ding, M., & Yang, H. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.311 · Cited by 86
Ahmadian, E., Khosroushahi, A. Y., Eftekhari, A., Farajnia, S., Babaei, H., & Eghbal, M. A. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.117 · Cited by 84
Catalano, V., Dentice, M., Ambrosio, R., Luongo, C., Carollo, R., Benfante, A., Todaro, M., Stassi, G., & Salvatore, D. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1542 · Cited by 83
ALDH1A inhibition sensitizes colon cancer cells to chemotherapy
Kozovská, Z., Patsalias, A., Bajzik, V., Durinikova, E., Demková, L., Jargasova, S., Smolková, B., Plavá, J., Kučerová, L., & Matúšková, M. (2018) · BMC Cancer · doi:10.1186/s12885-018-4572-6 · Cited by 83
Fiorillo, M., Tóth, F., Sotgia, F., & Lisanti, M. P. (2019) · Aging · doi:10.18632/aging.101905 · Cited by 83
Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma
Issa, M. E., Takhsha, F. S., Chirumamilla, C. S., Perez-Novo, C. A., Berghe, W. V., & Cuendet, M. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0319-5 · Cited by 82
Gao, C., Shen, Y., Jin, F., Miao, Y., & Qiu, X. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154576 · Cited by 80
Wu, C., Lusvarghi, S., Wang, J.-C., Hsiao, S.-H., Huang, Y.-H., Hung, T., & Ambudkar, S. V. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00274 · Cited by 80
Dent, P., Booth, L. A., Roberts, J. L., Liu, J., Poklepovic, A. S., Lalani, A. S., Tuveson, D. A., Martinez, J., & Hancock, J. F. (2019) · Oncogene · doi:10.1038/s41388-019-0849-8 · Cited by 80
Pan, Y., Chen, J., Tao, L., Zhang, K., Wang, R., Chu, X., & Chen, L. (2017) · Oncotarget · doi:10.18632/oncotarget.16562 · Cited by 78
The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer
Lü, T., Li, Z., Yang, Y., Ji, W., Yu, Y., Niu, X., Zeng, Q., Xia, W., & Lu, S. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.02.015 · Cited by 78
Critical role of STAT3 in melanoma metastasis through anoikis resistance
Fofaria, N. M., & Srivastava, S. (2014) · Oncotarget · doi:10.18632/oncotarget.2251 · Cited by 76
PGC1α induced by reactive oxygen species contributes to chemoresistance of ovarian cancer cells
Kim, B., Jung, J. W., Jung, J., Han, Y., Suh, D. H., Kim, H. S., Dhanasekaran, D. N., & Song, Y. S. (2017) · Oncotarget · doi:10.18632/oncotarget.19140 · Cited by 76
ATP-binding cassette member B5 (ABCB5) promotes tumor cell invasiveness in human colorectal cancer
Guo, Q., Grimmig, T., González, G., Giobbie‐Hurder, A., Berg, G., Carr, N., Wilson, B. J., Banerjee, P., Ma, J., Gold, J. S., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003187 · Cited by 74
Skoda, J., Borankova, K., Jansson, P. J., Huang, M., Veselská, R., & Richardson, D. R. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.020 · Cited by 72
Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells
Wu, Z., Teng, Q., Cai, C., Wang, J., Lei, Z., Yang, Y., Fan, Y., Zhang, J., Li, J., & Chen, Z. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.05.015 · Cited by 72
Huang, Y.-T., Lan, Q., Lorusso, G., Duffey, N., & Rüegg, C. (2016) · Oncotarget · doi:10.18632/oncotarget.13677 · Cited by 71
Liu, Y., Jiang, Z., Zhou, Y., Qiu, H., Wang, G., Luo, Y., Liu, J.-B., Liu, X., Bu, W., Song, J., et al. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.06.073 · Cited by 71
Nandy, S., Arumugam, A., Subramani, R., Pedroza, D. A., Hernandez, K. R., Saltzstein, E. C., & Lakshmanaswamy, R. (2015) · Oncotarget · doi:10.18632/oncotarget.3953 · Cited by 70
Sahu, S. K., Tiwari, N., Pataskar, A., Zhuang, Y., Borisova, M. E., Diken, M., Strand, S., Beli, P., & Tiwari, V. K. (2017) · Nature Communications · doi:10.1038/s41467-017-01366-x · Cited by 70
Lai, Q., Wang, H., Li, A., Xu, Y., Tang, L., Chen, Q., Zhang, C., Gao, Y., Song, J., & Du, Z. (2018) · Oncogene · doi:10.1038/s41388-018-0125-3 · Cited by 69
Giuntoli, S., Rovida, E., Barbetti, V., Cipolleschi, M. G., Olivotto, M., & Sbarba, P. D. (2006) · Leukemia · doi:10.1038/sj.leu.2404224 · Cited by 66
Chen, B., Zhang, D., Kuai, J., Cheng, M.-K., Fang, X., & Li, G. (2017) · Tumor Biology · doi:10.1177/1010428317715155 · Cited by 66
Temporal DNA-PK activation drives genomic instability and therapy resistance in glioma stem cells
Wang, Y., Xu, H., Liu, T., Huang, M., Butter, P.-P., Li, C., Zhang, L., Kao, G. D., Gong, Y., Maity, A. M., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.98096 · Cited by 65
MRN (MRE11-RAD50-NBS1) Complex in Human Cancer and Prognostic Implications in Colorectal Cancer
Situ, Y., Chung, L., Lee, C. S., & Ho, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040816 · Cited by 65
Zhang, R., Gao, S., Wang, Z., Han, D., Liu, L., Ma, Q., Tan, W., Tian, J., & Chen, X. S. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201701027 · Cited by 64
Ózsvári, B., Bonuccelli, G., Sánchez‐Alvarez, R., Foster, R., Sotgia, F., & Lisanti, M. P. (2017) · Aging · doi:10.18632/aging.101351 · Cited by 63
Huang, P., Kishida, S., Cao, D., Murakami‐Tonami, Y., Mu, P., Nakaguro, M., Koide, N., Takeuchi, I., Ōnishi, A., & Kadomatsu, K. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3524 · Cited by 62
Luo, Y., Yang, Z., Su, L., Shan, J., Xu, H., Xu, Y., Liu, L., Zhu, W., Chen, X., Liu, C., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.012 · Cited by 54
Matsumoto, T., Uchiumi, T., Monji, K., Yagi, M., Setoyama, D., Amamoto, R., Matsushima, Y., Shiota, M., Eto, M., & Kang, D. (2017) · Oncogenesis · doi:10.1038/s41389-017-0009-3 · Cited by 54
Bahmad, H. F., Mouhieddine, T. H., Chalhoub, R., Assi, S., Araji, T., Chamaa, F., Itani, M. M., Nokkari, A., Kobeissy, F. H., Daoud, G., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26088 · Cited by 54
Chen, L., Li, Y., Wu, L., Yu, G., Zhang, W., Huang, C., & Sun, Z. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13439 · Cited by 53
Cheng, X., Kim, J. Y., Ghafoory, S., Duvaci, T., Rafiee, R., Theobald, J., Alborzinia, H., Holenya, P., Fredebohm, J., Merz, K., et al. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.01.008 · Cited by 51
Cancer Stem Cells Protect Non‐Stem Cells From Anoikis: Bystander Effects
Kim, S., Hong, S., Basse, P. H., Wu, C., Bartlett, D. L., Kwon, Y. T., & Lee, Y. J. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25527 · Cited by 51
Wu, S. K., Akhtari, M., & Alachkar, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-31489-0 · Cited by 46
Abad, E., Garcia‐Mayea, Y., Mir, C., Sebastián, D., Antonio Zorzano, A., Potěšil, D., Zdráhal, Z., Lyakhovich, A., & LLeonart, M. E. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.001102 · Cited by 46
Self-citationAlsubhi, N. H., Middleton, F. K., Abdel-Fatah, T. M. A., Stephens, P., Doherty, R. E., Arora, A., Moseley, P. M., Chan, S. Y. T., Aleskandarany, M. A., Green, A. R., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.09.009 · Cited by 45
Angeletti, F., Fossati, G., Pattarozzi, A., Würth, R., Solari, A., Daga, A., Masiello, I., Barbieri, F., Florio, T., & Comincini, S. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00107 · Cited by 45
Ózsvári, B., Sotgia, F., & Lisanti, M. P. (2018) · Aging · doi:10.18632/aging.101384 · Cited by 44
Gleixner, K. V., Schneeweiss‐Gleixner, M., Eisenwort, G., Berger, D., Herrmann, H., Blatt, K., Greiner, G., Byrgazov, K., Hoermann, G., Konopleva, M. Y., et al. (2017) · Haematologica · doi:10.3324/haematol.2016.163436 · Cited by 42
Prabhu, V. V., Lulla, A. R., Madhukar, N. S., Ralff, M. D., Zhao, D., Kline, C. L. B., van den Heuvel, A. P. J., Lev, A., Garnett, M. J., McDermott, U., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180541 · Cited by 42
Replication stress response in cancer stem cells as a target for chemotherapy
Manic, G., Sistigu, A., Corradi, F., Musella, M., Maria, R. D., & Vitale, I. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.08.003 · Cited by 42
Petrachi, T., Romagnani, A., Albini, A., Longo, C., Argenziano, G., Grisendi, G., Dominici, M., Ciarrocchi, A., & Dallaglio, K. (2016) · Oncotarget · doi:10.18632/oncotarget.14321 · Cited by 41
Rafael, D. F. D. S., Gener, P., Andrade, F., Seras‐Franzoso, J., Montero, S., Fernández, Y., Hidalgo, M. M., Arango, D., Sayós, J., Florindo, H. F., et al. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1461276 · Cited by 41
Peroxiredoxin II Regulates Cancer Stem Cells and Stemness-Associated Properties of Cancers
Chandimali, N., Jeong, D. K., & Kwon, T. (2018) · Cancers · doi:10.3390/cancers10090305 · Cited by 40
Fujimoto, A., Kawana, K., Taguchi, A., Adachi, K., Sato, M., Nakamura, H., Ogishima, J., Yoshida, M., Inoue, T., Nishida, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10126 · Cited by 39
Salvianolic acid B reverses multidrug resistance in nude mice bearing human colon cancer stem cells
Guo, P., Wang, J., Gao, W., Liu, X., Wu, S., Wan, B., Xu, L., & Li, Y. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9086 · Cited by 39
Oo, A. K. K., Calle, A. S., Nair, N., Mahmud, H., Vaidyanath, A., Yamauchi, J., Khayrani, A. C., Du, J., Alam, M. J., Seno, A., et al. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.03.001 · Cited by 38
MicroRNA expression profiling in exosomes derived from gastric cancer stem-like cells
Sun, Z., Li, A.-Q., Jia, W.-H., Ye, S., Eps, G. V., Yu, J., & Yang, W. (2017) · Oncotarget · doi:10.18632/oncotarget.21288 · Cited by 37
Chemopreventive activity of celastrol in drug-resistant human colon carcinoma cell cultures
Moreira, H., Szyjka, A., & Gąsiorowski, K. (2018) · Oncotarget · doi:10.18632/oncotarget.25014 · Cited by 37
Spironolactone inhibits the growth of cancer stem cells by impairing DNA damage response
Gold, A., Eini, L., Nissim‐Rafinia, M., Viner‐Breuer, R., Ezer, S., Erez, K., Aqaqe, N., Hanania, R., Milyavsky, M., Meshorer, E., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0654-9 · Cited by 37
Sasaki, N., Ishiwata, T., Hasegawa, F., Michishita, M., Kawai, H., Matsuda, Y., Arai, T., Ishikawa, N., Aida, J., Takubo, K., et al. (2018) · Cancer Science · doi:10.1111/cas.13533 · Cited by 35
Pellegrini, P., Dyczynski, M., Sbrana, F. V., Karlgren, M., Buoncervello, M., Hägg-Olofsson, M., Ma, R., Hartman, J., Bajalica‐Lagercrantz, S., Grandér, D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9601 · Cited by 33
Release of c-FLIP brake selectively sensitizes human cancer cells to TLR3-mediated apoptosis
kurdi, L. A., Virard, F., Vanbervliet, B., Weber, K., Toscano, F., Bonnin, M., Stang, N. L., Lantuéjoul, S., Micheau, O., Renno, T., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0850-0 · Cited by 31
Oxidative Stress Resistance in Metastatic Prostate Cancer: Renewal by Self-Eating
Balvan, J., Gumulec, J., Raudenská, M., Křížová, A., Štěpka, P., Babula, P., Kizek, R., Adam, V., & Masařík, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145016 · Cited by 30
Autophagy inhibition as a promising therapeutic target for laryngeal cancer
Garcia‐Mayea, Y., Mir, C., Muñoz, L., Benavente, S., Castellví, J., Temprana‐Salvador, J., Maggio, V., Lorente, J., Paciucci, R., & LLeonart, M. E. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz080 · Cited by 30
Self-citationFan, F., Wang, R., Boulbés, D. R., Zhang, H., Watowich, S. S., Xia, L., Ye, X., Bhattacharya, R., & Ellis, L. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190070 · Cited by 27
PNPase knockout results in mtDNA loss and an altered metabolic gene expression program
Shimada, E., Ahsan, F. M., Nili, M., Huang, D., Atamdede, S., TeSlaa, T. A., Case, D., Yu, X., Gregory, B. D., Perrin, B. J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200925 · Cited by 26
Jokela, T. A., Engelsen, A. S. T., Rybicka, A. M., Vatter, F. A. P., Garbe, J. C., Miyano, M., Tiron, C. E., Ferariu, D., Akslen, L. A., Stampfer, M. R., et al. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00041 · Cited by 25
Arumugam, P., Samson, A. A. S., Ki, J., & Song, J. M. (2017) · Cell Biology and Toxicology · doi:10.1007/s10565-016-9378-1 · Cited by 24
Li, C., Fan, Q., Quan, H., Nie, M., Luo, Y., & Wang, L. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.03.033 · Cited by 23
Altered radiation responses of breast cancer cells resistant to hormonal therapy
Luzhna, L., Lykkesfeldt, A. E., & Kovalchuk, O. (2014) · Oncotarget · doi:10.18632/oncotarget.3188 · Cited by 22
Woo, S. M., Min, K., Seo, S. U., Kim, S., Kubatka, P., Park, J., & Kwon, T. K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133253 · Cited by 22
Chen, J., Wei, H., Cheng, J. J., Xie, B., Wang, B., Yi, J., Tian, B., Liu, Z., Wang, F., & Zhang, Z. (2017) · Oncology Letters · doi:10.3892/ol.2017.7353 · Cited by 21
Ahn, E. H., Lee, S. H., Kim, J. Y., Chang, C., & Loeb, L. A. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3462 · Cited by 20
Mielczarek-Lewandowska, A., Sztiller-Sikorska, M., Osrodek, M., Czyż, M., & Hartman, M. L. (2019) · APOPTOSIS · doi:10.1007/s10495-019-01542-y · Cited by 20
Wang, S., Wang, X., Zheng, K., Liu, K., Wang, S., & Xie, C. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.08.156 · Cited by 19
Nanayakkara, A. K., Vogel, P. D., & Wise, J. G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217940 · Cited by 19
Rigalli, J. P., Reichel, M., Tocchetti, G. N., Reuter, T., Dyckhoff, G., Herold‐Mende, C. C., & Weiß, J. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.04.036 · Cited by 18
Wang, Y., Yan, L., Zhang, L., Xu, H., Chen, T., Li, Y., Wang, H., Chen, S., Wang, W., Chen, C., et al. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4477 · Cited by 17
Pò, A., Abballe, L., Sabato, C., Gianno, F., Chiacchiarini, M., Catanzaro, G., Smaele, E. D., Giangaspero, F., Ferretti, E., Miele, E., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082326 · Cited by 17
Barrett, C. L., Schwab, R. B., Jung, H., Crain, B., Goff, D. J., Jamieson, C. H. M., Thistlethwaite, P. A., Harismendy, O., Carson, D. A., & Frazer, K. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058714 · Cited by 11
Cited by
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers
Liu, R., Chen, Y., Liu, G., Li, C., Song, Y., Cao, Z., Li, W., Hu, J., Lu, C., & Liu, Y. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-02998-6 · Cited by 923
Cancer stem cells: advances in knowledge and implications for cancer therapy
Chu, X., Tian, W., Ning, J., Xiao, G., Zhou, Y., Wang, Z., Zhai, Z., Tanzhu, G., Yang, J., & Zhou, R. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01851-y · Cited by 553
Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management
Jin, P., Jiang, J., Zhou, L., Huang, Z., Nice, E. C., Huang, C., & Fu, L. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01313-4 · Cited by 273
Lee, K.-L., Kuo, Y.-C., Ho, Y.-S., & Huang, Y.-H. (2019) · Cancers · doi:10.3390/cancers11091334 · Cited by 260
Metadata
- Authors
- Garcia-Mayea, Y., Mir, C., Masson, F., Paciucci, R., & LLeonart, M. E.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 60
- Pages
- 166-180
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2965561098
- Cited by
- 324
- References
- 202
- FWCI
- 13.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.